Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

ACAN Oblitoxaximab injection

Open
WS5994329939International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Public Services and Procurement Canada, on behalf of the Public Health Agency of Canada, has issued an Advanced Contract Award Notice for the procurement of Oblitoxaximab injection, an antitoxin used in the treatment of inhalation anthrax. The government intends to negotiate a contract with Elusys Therapeutics, Inc. unless other suppliers can demonstrate equivalent capabilities by the specified deadline. The solicitation, numbered WS5994329939, was posted on November 17, 2026, with a response deadline of December 8, 2026. This procurement is managed by the Department of Public Works and Government Services for performance within Canada. There is no specified set-aside status for this requirement.

General Info

Canada intends to procure Oblitoxaximab antitoxin from Elusys Therapeutics for inhalation anthrax treatment.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Due in 20 days

Get what you need to respond

No documents were posted with this contract.

  • Buyer contactEmail
  • Original solicitationLink to the source posting
Get the buyer contact

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Public Works and Government Services
Contacts1 person available
OfficeN/A

Full Description

Show more
Advanced Contract Award Notice(ACAN) - Oblitoxaximab Injection An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier. Purpose of this Advanced Contract Award Notice (ACAN): Public Services and Procurement Canada proposes to negotiate a contract with Elusys Therapeutics, Inc on behalf of Public Health Agency of Canada (PHAC). Requirement description: Public Health Agency of Canada (PHAC) has a requirement for Oblitoxaximab injection, an antitoxin used to treat inhalation anthrax.

Similar Contracts

Same NAICS industry code

NAICS: 325414
DIBBS
MEDICAL PHARMACY EMERGENCY NON NSN ORDER
Solicitation # SPE2DP-26-R-0004
Solicitation SPE2DP-26-R-0004 is a Request for Proposal issued on November 4, 2026, by the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of egg-free Influenza Virus Vaccine, 2027-2028 Formula for adults aged 18 and older. The government intends to award a Firm Fixed Price, Indefinite Delivery, Indefinite Quantity contract to the responsible offeror determined to be most advantageous based on price and non-price factors. Proposals must be submitted electronically via the DIBBS system by December 3, 2026. Award criteria include the proposed unit and total price, agreement to all solicitation terms without exception, and, for large businesses, the submission of a Small Business Subcontracting Plan. The contract mandates strict quality and cold chain management standards, requiring vaccines to be maintained between 2 to 8 degrees Celsius during transportation for up to 72 hours with no acceptable excursions. Products must be delivered to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, and must have an expiration date no later than 18 months after the date of issue from the manufacturer's cold storage. Manufacturers must be FDA current Good Manufacturing Practice acceptable. Packaging and marking must adhere to Medical Marking Standard No. 1D and MIL-STD-129 for perishables. Invoicing and payment will be processed electronically through the Wide Area Workflow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

14 days ago

DEADLINE

in 15 days
View Details

More opportunities from Government of Canada → Department of Public Works and Government Services

Same awarding agency

Get AI-powered intelligence on this solicitation and the ones like it

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS